Diabetes technology

Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide Continuous Glucose Monitoring (CGM) Policy With EHR-Integrated Validation for Dosing Insulin

Diabetes CarePublished Implementation study

Authors' conclusion

Implementation of a hospital-wide inpatient CGM policy supporting multiple CGM types with real-time accuracy monitoring and integration into the EHR is feasible. Initial feedback from nurses and patients was favorable, and further investigation toward broader use and sustainability is needed.

Study context

Population
Hospitalized patients with diabetes using personal CGMs in lieu of fingerstick blood glucose (FSBG) monitoring, Stanford Health Care, November 2022 to August 2023; 27% T1D, 24% on AID
Participants
135 patients185 inpatient encounters
Outcome
CGM validation attempts (n = 1,506)
Methodological detailssingle-centre, hospital-wide policy, electronic health record (EHR)-integrated validation, user experience surveys
  • Single-centre
  • Hospital-wide policy
  • EHR-integrated validation
  • User experience surveys

Performance

As reported in the abstract

Met the %20/20 criterion for CGM-based insulin dosing

87.8%

Within Clarke zones A or B

99.3%

Further findings

Nurse user experience survey (27 nurses)

Found glucose management under the protocol effective
74%
Found it easy to use
67%
Found it efficient
63%
Preferred inpatient CGM to FSBG
80%

Patient user experience survey (46 patients)

Liked the CGM protocol
63%
Reported positive CGM interactions with nursing staff
63%
Felt no significant interruptions to their diabetes management
63%

CGM types used

Dexcom G6
44%
FreeStyle Libre 2
43%

Original publication

Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin. Diabetes Care. Published 14 August 2024. doi:10.2337/dc24-0626

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.